BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 30543144)

  • 1. Effects of fluvoxamine on nerve growth factor-induced neurite outgrowth inhibition by dexamethasone in PC12 cells.
    Matsushima Y; Terada K; Takata J; Karube Y; Kamei C; Sugimoto Y
    Biosci Biotechnol Biochem; 2019 Apr; 83(4):659-665. PubMed ID: 30543144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of nerve growth factor-induced neurite outgrowth from PC12 cells by dexamethasone: signaling pathways through the glucocorticoid receptor and phosphorylated Akt and ERK1/2.
    Terada K; Kojima Y; Watanabe T; Izumo N; Chiba K; Karube Y
    PLoS One; 2014; 9(3):e93223. PubMed ID: 24667984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertraline inhibits nerve growth factor-induced neurite outgrowth in PC12 cells via a mechanism involving the sigma-1 receptor.
    Matsushima Y; Terada K; Kamei C; Sugimoto Y
    Eur J Pharmacol; 2019 Jun; 853():129-135. PubMed ID: 30902656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors.
    Terada K; Migita K; Matsushima Y; Sugimoto Y; Kamei C; Matsumoto T; Mori M; Matsunaga K; Takata J; Karube Y
    PLoS One; 2018; 13(12):e0209250. PubMed ID: 30557385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways.
    Nishimura T; Ishima T; Iyo M; Hashimoto K
    PLoS One; 2008 Jul; 3(7):e2558. PubMed ID: 18596927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.
    Ishima T; Fujita Y; Hashimoto K
    Eur J Pharmacol; 2014 Mar; 727():167-73. PubMed ID: 24508523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2X1 Receptor-Mediated Ca
    Back MJ; Lee HK; Lee JH; Fu Z; Son MW; Choi SZ; Go HS; Yoo S; Hwang SW; Kim DK
    ACS Chem Neurosci; 2016 Nov; 7(11):1488-1498. PubMed ID: 27442785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic effects of acrylamide in nerve growth factor or fibroblast growth factor 1-induced neurite outgrowth in PC12 cells.
    Chen JH; Lee DC; Chiu IM
    Arch Toxicol; 2014 Mar; 88(3):769-80. PubMed ID: 24318646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP3 receptors.
    Ishima T; Nishimura T; Iyo M; Hashimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1656-9. PubMed ID: 18647636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negletein as a neuroprotectant enhances the action of nerve growth factor and induces neurite outgrowth in PC12 cells.
    Phan CW; Sabaratnam V; Bovicelli P; Righi G; Saso L
    Biofactors; 2016 Nov; 42(6):591-599. PubMed ID: 27193378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells.
    Piiper A; Dikic I; Lutz MP; Leser J; Kronenberger B; Elez R; Cramer H; Müller-Esterl W; Zeuzem S
    J Biol Chem; 2002 Nov; 277(46):43623-30. PubMed ID: 12218049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of transglutaminase 2 by nerve growth factor in differentiating neuroblastoma cells: A role in cell survival and neurite outgrowth.
    Algarni AS; Hargreaves AJ; Dickenson JM
    Eur J Pharmacol; 2018 Feb; 820():113-129. PubMed ID: 29242118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptors.
    Ishima T; Hashimoto K
    PLoS One; 2012; 7(5):e37989. PubMed ID: 22655093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Kampo medicine Yokukansan (YKS) enhances nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells.
    Terada K; Matsushima Y; Matsunaga K; Takata J; Karube Y; Ishige A; Chiba K
    Bosn J Basic Med Sci; 2018 Aug; 18(3):224-233. PubMed ID: 28961087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical analysis of the nerve growth factor-dependent and nerve growth factor-independent differentiation signaling pathways in PC12 cells with protein kinase inhibitors.
    Campbell XZ; Neet KE
    J Neurosci Res; 1995 Oct; 42(2):207-19. PubMed ID: 8568921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcodonin G Derivatives Exhibit Distinctive Effects on Neurite Outgrowth by Modulating NGF Signaling in PC12 Cells.
    Cao CY; Zhang CC; Shi XW; Li D; Cao W; Yin X; Gao JM
    ACS Chem Neurosci; 2018 Jul; 9(7):1607-1615. PubMed ID: 29653489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoinhibin Suppresses the Neurotrophic Effects of VEGF and NGF in Newborn Rat Primary Sensory Neurons.
    Castillo X; Melo Z; Varela-Echavarría A; Tamariz E; Aroña RM; Arnold E; Clapp C; Martínez de la Escalera G
    Neuroendocrinology; 2018; 106(3):221-233. PubMed ID: 28571011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants.
    Takebayashi M; Hayashi T; Su TP
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1227-37. PubMed ID: 12438547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SH2B1beta enhances fibroblast growth factor 1 (FGF1)-induced neurite outgrowth through MEK-ERK1/2-STAT3-Egr1 pathway.
    Lin WF; Chen CJ; Chang YJ; Chen SL; Chiu IM; Chen L
    Cell Signal; 2009 Jul; 21(7):1060-72. PubMed ID: 19249349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of geldanamycin on neurite outgrowth-related proteins and kinases in nerve growth factor-differentiated pheochromocytoma 12 cells.
    Migita K; Matsumoto T; Terada K; Ono K; Hara S
    J Pharmacol Sci; 2019 Jul; 140(3):255-262. PubMed ID: 31402210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.